Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies.
Vaccine. 2022 Mar 18;40(13):1958-1967. doi: 10.1016/j.vaccine.2022.02.044. Epub 2022 Feb 15.
Vaccine. 2022.
PMID: 35193792
Free PMC article.
Amplified ELISA to detect autoantibodies to N-glycolyl-GM3 ganglioside.
Iznaga N, Carr A, Fernández LE, Solozabal J, Núñez G, Perdomo Y, Morales A.
Iznaga N, et al.
J Clin Lab Immunol. 1996;48(2):75-85.
J Clin Lab Immunol. 1996.
PMID: 16296265
Item in Clipboard
A personal computer-based system for parallel line analysis of bioassay data.
Iznaga N, Núñez G, Solozabal J, Morales A, Artaza E, Rubio R, Cardenas E.
Iznaga N, et al.
Comput Methods Programs Biomed. 1995 Jul;47(2):167-75. doi: 10.1016/0169-2607(95)01648-d.
Comput Methods Programs Biomed. 1995.
PMID: 7587163
Item in Clipboard
Affinity-matured variants derived from nimotuzumab keep the original fine specificity and exhibit superior biological activity.
Tundidor Y, Ponce LF, Chao L, Solozábal J, Hust M, Dübel S, Rojas G.
Tundidor Y, et al.
Sci Rep. 2020 Jan 27;10(1):1194. doi: 10.1038/s41598-019-57279-w.
Sci Rep. 2020.
PMID: 31988343
Free PMC article.
Item in Clipboard
Semi-mechanistic Pharmacokinetic/Pharmacodynamic model of three pegylated rHuEPO and ior®EPOCIM in New Zealand rabbits.
Reynaldo-Fernández G, Solozábal J, Amaro D, Fernández-Sánchez EM, Rodríguez-Vera L, Bermejo M, Mangas-Sanjuan V, Troconiz IF.
Reynaldo-Fernández G, et al.
Eur J Pharm Sci. 2018 Jul 30;120:123-132. doi: 10.1016/j.ejps.2018.04.047. Epub 2018 May 2.
Eur J Pharm Sci. 2018.
PMID: 29729414
Item in Clipboard
Molecular reshaping of phage-displayed Interleukin-2 at beta chain receptor interface to obtain potent super-agonists with improved developability profiles.
Rojas G, Relova-Hernández E, Pérez-Riverón A, Castro-Martínez C, Diaz-Bravo O, Infante YC, Gómez T, Solozábal J, DíazBravo AB, Schubert M, Becker M, Pérez-Massón B, Pérez-Martínez D, Alvarez-Arzola R, Guirola O, Chinea G, Graca L, Dübel S, León K, Carmenate T.
Rojas G, et al.
Commun Biol. 2023 Aug 9;6(1):828. doi: 10.1038/s42003-023-05188-0.
Commun Biol. 2023.
PMID: 37558752
Free PMC article.
Item in Clipboard
Cite
Cite